Berlin-Chemie AG - Company Review
Berlin-Chemie AG - Company ReviewSummary
Berlin-Chemie AG (Berlin Chemi), a subsidiary of A. Menarini Industrie Farmaceutiche Riunite Srl is a developer, manufacturer and distributor of drugs in various therapeutic areas. The company provides drugs in in the areas of pain medicine, gastroenterology, oncology, and neurology. It offers pharmaceutical products in various dosage forms such as tablets, film-coated tablets, capsules, liquids, solution, drops, suppositories, solutions for infusion. Berlin Chemi’s drugs are used in treatment of diabetes, erectile dysfunction, fever, cold, clinical nutrition and gastrointestinal, among others. The company partners with other companies for marketing of novel and ethical preparations. It operates in Germany, Bosnia and Herzegovina, Belarus, Albania, Moldova, Romania, Serbia, Slovakia, Armenia and Georgia. Berlin Chemi is headquartered in Berlin, Germany.
This comprehensive company report of Berlin-Chemie AG provides you with company's businesses and operations information.
The profile contains critical company information including,
- Company Overview - A detailed description of the company's operations and business divisions.
- Major products and services - A list of major products, services and brands of the company.
- Key competitors - A list of key competitors to the company.
- Key employees - A list of the key executives of the company.
- Important locations and subsidiaries - A list and contact details of key locations and subsidiaries of the company.
GlobalData is a one-stop solution for actionable insight into the pharmaceutical and medical device sectors. Together with the best team of researchers, analysts, epidemiologists and consultants, and an unmatched suite of proprietary databases, we provide high-quality, accurate and transparent insight that can help you achieve growth and increase business value.
Our valuable research and consulting solutions ensure you stay at the forefront of the industry by integrating accurate market forecasts and healthcare analytics on the latest trends and developments. Among other benefits, our informed healthcare industry perspectives have assisted businesses based across the pharmaceuticals, biotechnology and medical equipment markets in making strategic decisions that have increased the value of their products and services.
Unfortunately, this report is not available for the investor type or country you selected.
Browse all ResearchPool reportsReport is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.